UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of the consumption of tomato paste on plasma prostate-specific antigen levels in patients with benign prostate hyperplasia

Brazilian journal of medical and biological research, 2006-08, Vol.39 (8), p.1115-1119

2006

Volltextzugriff (PDF)

Replicating viral vectors as HIV vaccines: Summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference

Biologicals, 2010-07, Vol.38 (4), p.511-521

2010

Volltextzugriff (PDF)

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

The New England journal of medicine, 2013-07, Vol.369 (3), p.213-223

2013

Volltextzugriff (PDF)

Analysis of KIR gene frequencies and HLA class I genotypes in prostate cancer and control group

International journal of immunogenetics, 2012-10, Vol.39 (5), p.423-428

2012

Volltextzugriff (PDF)

Vector induced skewing of antibody Fc-effector functions

Retrovirology, 2012-09, Vol.9 (S2), p.P361-P361, Article P361

2012

Volltextzugriff (PDF)

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses

Retrovirology, 2012-09, Vol.9 (S2), p.O7-O7, Article O7

2012

Volltextzugriff (PDF)

P04-51 LB. The epitopes of two newly identified broad and potent neutralizing antibodies, PG9 and PG16

Retrovirology, 2009-10, Vol.6 (S3), p.P391-P391, Article P391

2009

Volltextzugriff (PDF)

S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.O6-O6, Article O6

2009

Volltextzugriff (PDF)

Replicating viral vectors as HIV vaccines Summary Report from IAVI Sponsored Satellite Symposium, International AIDS Society Conference, July 22, 2007

Biologicals, 2008-09, Vol.36 (5), p.277-286

2008

Volltextzugriff (PDF)

A randomised, double-blind study comparing the efficacy and tolerability of controlled-release doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia in Brazil

International journal of clinical practice (Esher), 2006-10, Vol.60 (10), p.1172-1177

2006

Volltextzugriff (PDF)

Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines

Vaccine, 2013-04, Vol.31, p.B204-B208

2013

Volltextzugriff (PDF)

Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1

AIDS research and human retroviruses, 1997-11, Vol.13 (16), p.1421-1428

1997

Volltextzugriff (PDF)

Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones

The Journal of immunology (1950), 1985-07, Vol.135 (1), p.350-354

1985

Volltextzugriff (PDF)

Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine

Infection and Immunity, 1997-05, Vol.65 (5), p.1716-1721

1997

Volltextzugriff (PDF)

Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals

AIDS research and human retroviruses, 2000-03, Vol.16 (4), p.337-343

2000

Volltextzugriff (PDF)

HIV vaccine design and the neutralizing antibody problem

Nature immunology, 2004-03, Vol.5 (3), p.233-236

2004

Volltextzugriff (PDF)

A Dose-Ranging Study of a Prototype Synthetic HIV-1MN V3 Branched Peptide Vaccine

The Journal of infectious diseases, 1996-02, Vol.173 (2), p.330-339

1996

Volltextzugriff (PDF)

AIDS vaccines and preexposure prophylaxis: is synergy possible?

AIDS research and human retroviruses, 2011-06, Vol.27 (6), p.669-680

2011

Volltextzugriff (PDF)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies

Retrovirology, 2012-09, Vol.9 (S2), p.P48-P48, Article P48

2012

Volltextzugriff (PDF)

HIV vaccine design: insights from live attenuated SIV vaccines

Nature immunology, 2006-01, Vol.7 (1), p.19-23

2006

Volltextzugriff (PDF)

DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity

Vaccine, 1997-07, Vol.15 (10), p.1049-1056

1997

Volltextzugriff (PDF)

A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies

Retrovirology, 2012-09, Vol.9 (S2), p.O29-O29, Article O29

2012

Volltextzugriff (PDF)

Malformations of the Epididymis in Undescended Testis

The Journal of urology, 1990-02, Vol.143 (2), p.340-343

1990

Volltextzugriff (PDF)

Viral vector delivery of Env trimer immunogens

Retrovirology, 2012-09, Vol.9 (S2), p.P341-P341, Article P341

2012

Volltextzugriff (PDF)

1 – 25 von 385

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(328)
Mit Volltextzugriff
(289)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(223)
Humans
(174)
Life Sciences & Biomedicine
(171)
Male
(88)
Biological And Medical Sciences
(80)
Female
(66)
Medical Sciences
(58)
Adult
(55)
Animals
(54)
Middle Aged
(49)
Immunology
(44)
Aged
(41)
Physical Sciences
(35)
Astronomy & Astrophysics
(30)
Microbiology
(30)
Fundamental And Applied Biological Sciences. Psychology
(29)
Mice
(28)
Infectious Diseases
(27)
Aids/hiv
(26)
Vaccines
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effect of the consumption of tomato paste on plasma prostate-specific antigen levels in patients with benign prostate hyperplasia

Replicating viral vectors as HIV vaccines: Summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Analysis of KIR gene frequencies and HLA class I genotypes in prostate cancer and control group

Vector induced skewing of antibody Fc-effector functions

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses

P04-51 LB. The epitopes of two newly identified broad and potent neutralizing antibodies, PG9 and PG16

S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target

Replicating viral vectors as HIV vaccines Summary Report from IAVI Sponsored Satellite Symposium, International AIDS Society Conference, July 22, 2007

A randomised, double-blind study comparing the efficacy and tolerability of controlled-release doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia in Brazil

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial

Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines

Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1

Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones

Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine

Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals

HIV vaccine design and the neutralizing antibody problem

A Dose-Ranging Study of a Prototype Synthetic HIV-1MN V3 Branched Peptide Vaccine

AIDS vaccines and preexposure prophylaxis: is synergy possible?

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies

HIV vaccine design: insights from live attenuated SIV vaccines

DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity

A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies

Malformations of the Epididymis in Undescended Testis

Viral vector delivery of Env trimer immunogens

Suchergebnisse filtern